豐德麗控股(00571.HK)中期營業額5.07億港元 同比增長78.3%
格隆匯3月22日丨豐德麗控股(00571.HK)公吿,截至2022年1月31日止六個月,公司營業額5.07億港元,同比增長78.3%;公司擁有人應占虧損1.28億港元,上年同期虧損7574萬港元;每股虧損0.086港元。
於回顧期間內,集團新增三家於香港營運的戲院,即K11 Art House、MCL東薈城戲院及MCL淘大戲院,而在2022年一月第五波COVID-19個案急升前,特別是節日假期期間,其於香港戲院的票房表現較去年同期大幅增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.